Table 2 Distribution of genetic alterations across molecular groups.
Altered marker | WNT (n = 9) | SHH TP53- (n = 13) | SHH TP53+ (n = 10) | Non-WNT/non-SHH (n = 51) | NOS (n = 1) |
|---|---|---|---|---|---|
GAB1 | 1/9 | 8/13 | 8/10 | 2/51 | 0/1 |
YAP1 | 4/9 | 10/13 | 8/10 | 2/51 | 0/1 |
CTNNB1 (β-Catenin) | 4/9 | 0/13 | 0/10 | 0/51 | 0/1 |
TP53 (P53) | 2/9 | 0/13 | 10/10 | 12/51 | 0/1 |
Mon Chr. 6 | 5/9 | 0/13 | 0/10 | 0/51 | 0/1 |
i17q | 0/9 | 0/13 | 0/10 | 11/51 | 0/1 |
MYCN | 0/9 | 0/13 | 3/10 | 15/51 | 0/1 |
MYC | 1 /9 | 0/13 | 0/10 | 7/51 | 0/1 |